Colorectal Cancer Study
Colorectal cancer, also known as bowel cancer, colon cancer, or rectal cancer, is any cancer that affects the colon and the rectum. The American Cancer Society estimate that about 1 in 21 men and 1 in 23 women in the United States will develop colorectal cancer during their lifetime.
- The main goal of the Study is to collect health information and blood samples from people who are at average risk for colorectal cancer and are scheduled to undergo a routine colonoscopy screening test.
- Males or females 45-84 intending to undergo screening colonoscopy
- Considered by a physician or healthcare provider as being of ‘average risk’ for CRC
- Willing to consent to blood draw pre-bowel preparation administration prior to undergoing colonoscopy within 60 days of the date of the investigational blood draw
- Willing to continue follow ups for up to 2 years
If Qualified & you Participate you will Receive;
- Study-related care at no cost
- Highest standards of care overseen by a licensed Physician
- Compensation for time and travel
- Insurance is not required
Fill out the form on the right-hand side of the page and see if you qualify for our clinical trial →